Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: Rhatz who wrote (2019)	7/22/1998 6:18:00 PM
From: TJG	Read Replies (1) \| Respond to of 2395

Just some DD on the competition..Cell Robotics International BUSINESS: ÿMedical Devicesÿ RESEARCH:ÿÿCLICK HERE ...news alerts, website, message boards, Edgar filings, CEO interviews/Q&A, customer satisfaction ratings, and other relative links. ÿÿÿÿÿÿÿ This is a development stage company. As such, it is difficult to analyze and draw conclusions about future potential business. ÿÿ Rating Summary (1 to 5, with 5 high) ÿÿÿÿÿÿÿ Management -- needs to recruit experienced profit & loss-oriented, senior management "from the industry" [1] ÿÿÿÿÿÿÿ Market growth -- home market for relatively painless diabetic testing [4] ÿÿÿÿÿÿÿ Market domination -- product leadership creates a current selling advantage [3] ÿÿÿÿÿÿÿ Proprietary -- paradigm shift product, only one with FDA clearance for diabetics at clinics [3]. ÿÿÿÿÿÿÿ The above rating assumes the company shortly will sell or spin-off all "non-paradigm shift products", and focus only on the Lasette. The Lasette is a FDA approved micro-laser device for clinics. It helps nurses monitor glucose (blood sugar) levels for diabetics and near diabetics, almost painlessly. ÿÿÿMAJOR Paradigm Shift for diabetic blood monitoring, especially in the home ÿÿÿÿÿÿÿ (1) Urine samples were used to monitor diabetic glucose (blood sugar) levels. ÿÿÿÿÿÿÿ (2) For the last 20 years glucose has been tested using blood drawn with steel lancets, which can be painful. ÿÿÿÿÿÿÿ (3) The Cell Robotics microlaser-based Lasette provides a non-invasive, nearly painless way to monitor glucose (blood sugar) levels. On October 30, 1997 the company received FDA approval to market the Lasette to clinics. ÿÿÿÿÿÿÿ (4) In clinical settings, the Lasette also eliminates cross-contamination risks to nurses from accidental sticks with sharp steel lancets while treating HIV positive and AIDs patients. ÿÿÿÿÿÿÿ (5) An FDA application is in process to allow home sales to diabetics, which could be a substantial market. ÿÿThe Company ÿÿÿÿÿÿÿ Cell Robotics historically sold products to the scientific marketplace. The company is trying to transition to consumer and clinical marketplaces. Based on microlaser technology, other non-scientific products provide applications for (a) cosmetic uses such as skin resurfacing and wrinkle removal and (b) IN VITRO fertilization. Over the years the company received (and spent) almost $13 million. ÿÿÿÿÿÿÿ With only 15 employees, Cell Robotics must focus, focus, focus to dominate one market -- the clinical (and home if FDA-approved) market for non-invasive, glucose (blood sugar) testing devices for diabetics. The other businesses, in our opinion, should be sold, spun-off, or shut down, so that they do not detract from the singular domination goal. ÿÿÿThe Offering ÿÿÿÿÿÿÿ The $20 preferred stock unit is convertible to 4 stock shares and includes two $5 warrants. This is the first SB-2 offering for the company, which went public via a reverse merger in 1995 and is traded OTC BB: CRII Rating: on a scale of 1 to 5 -with 5 being high...ÿ Proven Management: 1ÿÿ Market Growth: 4ÿÿ Market Domination: 3ÿÿ Proprietary:ÿ 3 Financial Overview...ÿ Post Offering Market Capÿ $30 million Times Sales ÿ 25 Times Earnings ÿÿÿ Losses Times Net Worth ÿ 5 Primary use of Proceeds:ÿÿsales & marketing; working capital, equipment Offering Size:ÿÿmax. $8 million Underwriter:ÿÿPaulson Investment Company; Cohig & Associates GASKINS/Co Investment Community - 310-826-6017 - fgaskins@gaskinsco.comÿ TJG